JVMCX
Price
$28.77
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
LMCHX
Price
$37.11
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

JVMCX vs LMCHX

Header iconJVMCX vs LMCHX Comparison
Open Charts JVMCX vs LMCHXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$28.77
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Lord Abbett Mid Cap Stock R6
Price$37.11
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMCX vs LMCHX Comparison Chart
Loading...
VS
JVMCX vs. LMCHX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and LMCHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 23.1B vs. LMCHX (1.19B). LMCHX pays higher dividends than JVMCX: LMCHX (0.70) vs JVMCX (0.01). JVMCX was incepted earlier than LMCHX: JVMCX (13 years) vs LMCHX (9 years). JVMCX (41.00) and LMCHX (41.00) have comparable annual turnover. LMCHX has a lower initial minimum investment than JVMCX: LMCHX (0) vs JVMCX (1000). LMCHX annual gain was more profitable for investors over the last year : 23.76 vs. JVMCX (14.99). LMCHX (37.67) and JVMCX (37.53) have equivalent 5 years return.
JVMCXLMCHXJVMCX / LMCHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years9 years-
Gain YTD9.33614.43465%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.1B1.19B1,938%
Annual Yield % from dividends0.010.702%
Returns for 1 year14.9923.7663%
Returns for 3 years7.779.4283%
Returns for 5 years37.5337.67100%
Returns for 10 years47.55N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAC39.870.47
+1.19%
Camden National Corp
DLB72.680.80
+1.11%
Dolby Laboratories IncClass A
JBLU5.72-0.03
-0.52%
JetBlue Airways Corp
SWIN2.67-0.08
-2.91%
Solowin Holdings Ordinary Share
SEEL0.20-0.03
-11.51%
Seelos Therapeutics Inc.